Evidence map›Paper›PMID 9858533›Full record

ArticleMolecular and cellular biology1999

Polypyrimidine tract-binding protein positively regulates inclusion of an alternative 3'-terminal exon.

H Lou, D M Helfman, R F Gagel, S M Berget

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 148 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PTBP1 Positively Regulates the Translation of Circadian Clock Gene,International journal of molecular sciences · 2020
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

H LouVerna and Marrs McLean Department of Biochemistry, Baylor College of Medicine, Houston, Texas 77030, USA. hlou@bcm.tmc.edu
D M Helfman
R F Gagel
S M Berget
Baylor College of Medicine · USCold Spring Harbor Laboratory · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
CONTROL OF CALCITONIN GENE EXPRESSIONR01DK038146 · NIDDK · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI GAGEL, ROBERT F. · 1988 to 1995
–
TROPOMYOSIN GENE STRUCTURE, EXPRESSION AND REGULATIONR01GM043049 · NIGMS · COLD SPRING HARBOR LABORATORY · PI HELFMAN, DAVID M · 1989 to 1997
–
NCI NIH HHS 2P30-CA16672NCI NIH HHS P30 CA016672NIDDK NIH HHS R01-DK38146NIGMS NIH HHS GM43049
6 · The paper itself

Abstract

Polypyrimidine tract-binding protein (PTB) is an abundant vertebrate hnRNP protein. PTB binding sites have been found within introns both upstream and downstream of alternative exons in a number of genes that are negatively controlled by the binding of PTB. We have previously reported that PTB binds to a pyrimidine tract within an RNA processing enhancer located adjacent to an alternative 3'-terminal exon within the gene coding for calcitonin and calcitonin gene-related peptide. The enhancer consists of a pyrimidine tract and CAG directly abutting on a 5' splice site sequence to form a pseudoexon. Here we show that the binding of PTB to the enhancer pyrimidine tract is functional in that exon inclusion increases when in vivo levels of PTB increase. This is the first example of positive regulation of exon inclusion by PTB. The binding of PTB was antagonistic to the binding of U2AF to the enhancer-located pyrimidine tract. Altering the enhancer pyrimidine tract to a consensus sequence for the binding of U2AF eliminated enhancement of exon inclusion in vivo and exon polyadenylation in vitro. An additional PTB binding site was identified close to the AAUAAA hexanucleotide sequence of the exon 4 poly(A) site. These observations suggest a dual role for PTB in facilitating recognition of exon 4: binding to the enhancer pyrimidine tract to interrupt productive recognition of the enhancer pseudoexon by splicing factors and interacting with the poly(A) site to positively affect polyadenylation.

Indexed as

ExonsNuclear ProteinsAnimalsBinding SitesCHO CellsConsensus SequenceCricetinaeEnhancer Elements, GeneticHeLa CellsHumansPolypyrimidine Tract-Binding ProteinRecombinant Fusion ProteinsRibonucleoproteinsRNA-Binding ProteinsRNA SplicingSplicing Factor U2AFNuclear ProteinsPolypyrimidine Tract-Binding ProteinRecombinant Fusion ProteinsRibonucleoproteinsRNA-Binding ProteinsSplicing Factor U2AFU2AF2 protein, human

Identifiers

PMID9858533
PMCPMC83867
OpenAlexW1823764696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.